Showing results for 'N'
Total number of hits: 17
Click on results for more details:
PDIDC100
Clorazepate
Active compound: Nordazepam
Indications: Epilepsy
Target: GABA-A receptors
PDIDD033
Droxidopa
Active compound: Norepinephrine
Indications: Orthostatic dizziness, lightheadedness, or the ‘‘feeling that you are about to black out’’ in adult patients, Parkinsonism
Target: Adrenergic receptor
PDIDE022
Ethynodiol
Active compound: Norethisterone
Indications: Na
Target: Progesterone receptor and estrogen receptor alpha (KEGG)
PDIDE023
Ethynodiol diacetate
Active compound: Norethisterone
Indications: For the prevention of pregnancy
Target: Progesterone receptor and estrogen receptor alpha (KEGG)
PDIDF021
Fosnetupitant
Active compound: Netupitant
Indications: Acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy; acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy
Target: Neurokinin-1 (NK-1) receptors
PDIDG007
Glyceryl Trinitrate
Active compound: Nitric oxide (NO)
Indications: Angina and Heart failure
Target: Quorum sensing-regulated virulence
PDIDL020
Lynestrenol
Active compound: Norethisterone
Indications: Menorrhagia; Metrorrhagia; Myomas; Chronic hip pains; Dysmenorrhea (R1); 2) Hepatic Disease; Vaginal Bleeding; Myocardial Infarction; Vascular Disease; Deep vein thrombosis (R 2)
Target: Progesterone receptor
PDIDN002
Nandrolone decanoate
Active compound: Nandrolone
Indications: Refractory deficient red cell production anemias; Breast carcinoma; Hereditary angioedema; Antithrombin III deficiency; Fibrinogen excess; growth failure and Turner's syndrome (WL1)
Target: Androgen receptor (WL1)
PDIDN003
Nandrolone phenylpropionate
Active compound: Nandrolone
Indications: Breast cancer; Osteoporosis (WL1)
Target: Androgen receptor (WL1)
PDIDN008
Nicotinamide
Active compound: N-methylnicotinamide
Indications: Anticoagulant; Peeling red skin; Niacin deficiency; Acne
Target: Platelet p2y12 receptor
PDIDN010
Norethisterone acetate
Active compound: Norethisterone
Indications: Amenorrhea, functional uterine bleeding, endometriosis, and for contraception (Ref 1)
Target: Progesterone receptor (Ref 2)
PDIDP006
Paracetamol
Active compound: N-arachidonoylphenolamine
Indications: Pain and fever.
Target: Cyclooxygenase (COX), TRPA1-receptors
PDIDP008
PBBG (Pyrrolo[2,1-c][1,4]-benzodiazepine-beta-glucuronide)
Active compound: NSC718813
Indications: Solid tumors
Target: DNA minor groove
PDIDQ003
Quingestanol
Active compound: Norethisterone
Indications: Endometriosis-related pain; Postmenopausal osteoporosis and moderate-to-severe vasomotor symptoms arising from menopause
Target: Progesterone receptor
PDIDQ004
Quingestanol acetate
Active compound: Norethisterone
Indications: Oral contraceptives
Target: Progesterone receptor
PDIDT005
Talniflumate
Active compound: Niflumic acid
Indications: Rheumatoid arthritis and osteoarthritis
Target: Chloride channel protein ClC-Ka; Prostaglandin G/H synthase 1; Prostaglandin G/H synthase 2
PDIDT031
Tilidine
Active compound: Nortilidine
Indications: Pain
Target: μ-opioid receptors